Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT06212960 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-04-04
Summary
To evaluate the safety of 12-week administration of DWP712 inj. in subjects with moderate to severe glabellar lines.
Conditions
- Glabellar Lines
Interventions
- BIOLOGICAL
-
DWP712
Clostridium botulinum Toxin
- BIOLOGICAL
-
BOTOX®
Clostridium botulinum Toxin
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Principal Investigators
-
Beom Joon Kim, MD, Ph.D · Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-28
- Primary Completion
- 2024-02-26
- Completion
- 2024-03-21
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01237977 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
NCT02568150 ·Status: COMPLETED ·Phase: PHASE4
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
NCT05059587 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
NCT05804656 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014622 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014635 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
NCT05463965 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Moderate to Severe Glabellar Lines
NCT04249583 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
NCT03004248 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
NCT01391312 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
NCT02961673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
NCT03970876 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
NCT04143815 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
NCT02882893 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
NCT05292638 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
NCT06124794 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines
NCT03408236 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)
NCT03894748 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03736928 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
NCT06308198 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
NCT04225260 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
NCT03184363 ·Status: UNKNOWN ·Phase: PHASE3